Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins

Infection and Immunity

Volumn 68, Issue 9, 2000, Pages 4980-4985

  Hu, W G ^a   Chen, J ^a   Battey, J F ^a   Gu, X X ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; BACTERICIDAL ACTIVITY; DETOXIFICATION; FEMALE; HAEMOPHILUS INFLUENZAE; LUNG CLEARANCE; MORAXELLA CATARRHALIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL VACCINES; FEMALE; IMMUNIZATION; IMMUNIZATION, PASSIVE; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED BALB C; MORAXELLA (BRANHAMELLA) CATARRHALIS; RABBITS; VACCINATION;

EID: 0033849901     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.9.4980-4985.2000     Document Type: Article

References (45)

1. Mechanisms of phagocytosis in macrophages
2. Antimicrobial treatment of sinusitis
3. Development of serum bactericidal activity following nontypable Haemophilus influenzae acute otitis media
4. Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis
5. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine
6. Otitis media and sinusitis in children. Role of Branhamella catarrhalis
7. Immunoglobulin
8. Branhamella catarrhalis: An organism gaining respect as a pathogen
9. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization
10. Clearance of bacteria from lungs of mice after opsonising with IgG or IgA
11. Neonatal meningitidis due to Moraxella catarrhalis and review of the literature
12. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: Results of a 30-center national surveillance study
13. Animal models of otitis media: Other pathogens
14. The respiratory system
15. Proinflammatory cytokines and immunity
16. Moraxella (Branhamella) catarrhalis clinical and molecular aspects of a rediscovered pathogen
17. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: Relationship to otitis media
18. Immune response to Moraxella catarrhalis in children with otitis media: Opsonophagocytosis with antigen-coated latex beads
19. Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines
20. FC gamma receptor mediated phagocytosis by human neutrophil cytoplasts
21. Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains
22. Nontypeable Haemophilus influenzae: Pathogenesis and prevention
23. The function of antibody and complement in the lysis of bacteria
24. Susceptibility of Moraxella catarrhalis isolates to beta-lactam antibiotics in relation to beta-lactamase pattern
25. Children with persistent cough outcome with treatment and role of Moraxella catarrhalis
26. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis
27. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins
28. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model
29. An aerosol challenge mouse model for Moraxella catarrhalis
30. Spectrum and significance of bacteremia due to Moraxella catarrhalis
31. The complement system
32. Moraxella (Branhamella) catarrhalis bacteremia in children. A report of two cases and review of the literature
33. Branhamella catarrhalis: Epidemiology, surface antigenic structure, and immune response
34. Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model
35. The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen
36. Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection
37. Pulmonary host defenses in rabbits after immunization with Pseudomonas antigens: The interaction of bacteria, antibodies, macrophages, and lymphocytes
38. Phagocytic defense in the lung
39. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines
40. Biochemical analysis of lipopolysaccharides from respiratory pathogenic Branhamella catarrhalis strains and the role of anti-LPS antibodies in Branhamella respiratory infections
41. Epidemiology of otitis media during the first seven years of life in children in greater Boston: A prospective, cohort study
42. The relationship of inoculum size to lung bacterial clearance and phagocytic cell response in mice
43. Pulmonary clearance of Moraxella catarrhalis in an animal model
44. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens
45. Anaphylatoxin C3a but not C3a (desArg) is a chemotaxin for the mouse macrophage cell line J774